Radiofrequency ablation and chemoembolization for hepatocellular carcinoma

Cancer Journal

Volumn 14, Issue 2, 2008, Pages 117-122

  Georgiades, Christos S ^a   Hong, Kelvin ^a   Geschwind, Jean Francois ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

ANTIEMETIC AGENT; BEVACIZUMAB; DOXORUBICIN; IODINATED POPPYSEED OIL; SORAFENIB; ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ABSCESS; BILE DUCT INJURY; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; DIGESTIVE SYSTEM INJURY; FEVER; GALLBLADDER TRAUMA; HUMAN; INFECTION; INTESTINE INJURY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; NAUSEA; NERVE INJURY; PATIENT SELECTION; PNEUMOTHORAX; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SAFETY; TREATMENT RESPONSE; TUMOR LYSIS SYNDROME; ARTICLE; CATHETER ABLATION; LIVER TUMOR; MULTIMODALITY CANCER THERAPY;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS;

EID: 50949120748     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31816a0fac     Document Type: Review

References (24)

1. Ramsey DE, Kernagis LY, Soulen MC, et al. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9 Pt 2):S211-S221.
2. Ramsey DE, Geschwind JF. Chemoembolization of hepatocellular carcinoma - what to tell the skeptics: review and meta-analysis. Tech Vasc Interv Radiol. 2002;5:122-126.
3. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg. 2002;194:813-828.
4. Hong K, Georgiades CS, Geschwind JF. Technology insight: image-guided therapies for hepatocellular carcinoma - intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315-324.
5. Zhu AX. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer. 2008;112:250-259.
6. Gasparini D, Sponza M, Marzio A, et al. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol Med (Torino). 2002;104:412-420.
7. Yokoyama T, Egami K, Miyamoto M, et al. Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg. 2003;10:425-427.
8. Guglielmi A, Ruzzenente A, Sandri M, et al. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg. 2007;11:143-149.
9. Arch-Ferrer JE, Smith JK, Bynon S, et al. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am Surg. 2003;69: 1067-1071.
10. Ferrari FS, Megliola A, Scorzelli A, et al. Treatment of small HCC through radiofrequency ablation and laser ablation: comparison of techniques and long-term results. Radiol Med (Torino). 2007;112:377-393.
11. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000; 214:761-768.
12. Camma C, Di Marco V, Orlando A, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol. 2005;42:535-540.
13. Crucitti A, Danza FM, Antinori A, et al. Radiofrequency thermal ablation (RFA) of liver tumors: percutaneous and open surgical approaches. J Exp Clin Cancer Res. 2003;22(4 Suppl):191-195.
14. Georgiades CS, Hong K, Geschwind JF. Pre-and postoperative clinical care of patients undergoing interventional oncology procedures: a comprehensive approach to preventing and mitigating complications. Tech Vasc Interv Radiol. 2006;9:113-124.
15. Georgiades CS, Hong K, D'Angelo M, et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:1653-1659.
16. Hong K, Khwaja A, Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006;12:2563-2567.
17. Malagari K, Chatzimichael K, Alexopoulou E, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients [published online ahead of print November 13, 2007]. DOI:10.1007/s00270-007-9226-z. Cardiovasc Intervent Radiol.
18. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164-1171.
19. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-442.
20. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47-54.
21. Carr BI. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Hepatogastroenterology. 2002;49:79-86.
22. Herber S, Schneider J, Brecher B, et al. TACE: therapy of the HCC before liver transplantation - experiences. Rofo. 2005;177:681-690.
23. Lesurtel M, Mullhaupt B, Pestalozzi BC, et al. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant. 2006;6:2644-2650.
24. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661-669.